SABBY 13G GALT 11.23.15

Company

GALECTIN THERAPEUTICS INC

Filed

November 23, 2015

Accession Number

0001535610-15-000076

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →